The global market size of biopsy devices is projected to reach USD 2.7 billion by 2024, increasing over the forecast period at a CAGR of 6.2%. Factors such as rising cancer prevalence shifting to minimally invasive surgery, the efforts by government and global health organizations to raise awareness of cancer, and the improved reimbursement scenario in the U.S. are driving global market development.